Sfoglia per Rivista PAGE
Evaluating the inclusion of the particle size distribution in the lung dissolution model of a WB-PBPK model to describe the pharmacokinetics of inhaled polydisperse drugs
2018-01-01 Grandoni, S.; Cesari, N.; Brogin, G.; Puccini, P.; Magni, P.
Evaluating the Influence of Different Sources of Variability in the PK/PD Tumor Growth Inhibition (TGI) Model
2008-01-01 F., Del Bene; M., Germani; F., Fiorentini; DE NICOLAO, Giuseppe; Magni, Paolo; M., Rocchetti
Evaluation of a minimal WB-PBPK platform supporting different routes of administration
2017-01-01 Grandoni, Silvia; Bigoni, Giulia; Cesari, N.; Puccini, P.; Brogin, G.; Magni, Paolo
Evaluation of a PK/PD DEB-based model for tumor-in-host growth kinetics under anticancer treatment
2016-01-01 Tosca, ELENA MARIA; Borella, Elisa; Terranova, Nadia; Rocchetti, M.; Magni, Paolo
Evaluation of software tools for Bayesian estimation on population models with count and continuous data
2015-01-01 Borella, Elisa; Carrara, Letizia; Lavezzi, SILVIA MARIA; Mezzalana, Enrica; Pasotti, Lorenzo; DE NICOLAO, Giuseppe; Magni, Paolo
Evaluation of software tools for Bayesian estimation on population models:an update based on current software versions
2018-01-01 Bartolucci, R.; Lavezzi, S. M.; Tosca, E. M.; Melillo, N.; Grandoni, S.; Borella, E.; Pasotti, L.; De Nicolao, G.; Magni, P.
Execution of complex Bayesian workflows with the DDMoRe Interoperability Framework: a case study in the diabetes area
2017-01-01 Larizza, Cristiana; Borella, Elisa; Pasotti, Lorenzo; Tartaglione, Palma; Smith, M.; Moodie, S.; Magni, Paolo
Facing the limits of the genetic algorithms for covariate selection
2022-01-01 Ronchi, D.; Tosca, E. M.; Ravasi, I.; Bartolucci, R.; Magni, P.
First-order longitudinal population model of FEV1 data: single-trial modeling and meta-analysis
2013-01-01 Marostica, Eleonora; S., Yang; Russu, Alberto; DE NICOLAO, Giuseppe; S., Zamuner; M., Beerahee
Global sensitivity analysis of a physiologically based pulmonary absorption model
2019-01-01 Melillo, N.; Grandoni, S.; Cesari, N.; Brogin, G.; Puccini, P.; Magni, P.
Impact of sampling procedure on individual pharmacokinetic parameter estimation methods
2024-01-01 Cuquerella-Gilabert, M.; Sanchez Herrero, S.; Merino Sanjuan, M.; Tosca, E. M.; Mangas Sanjuan, V.; Magni, P.
In vitro-in vivo correlation (IVIVC) population modeling for the in silico bioequivalence of a long-acting release formulation of Progesterone
2018-01-01 Tosca, E. M.; De Nicolao, G.; Rochetti, M.; Magni, P.; Perez, E.; Nieto, C.; Bettica, P.; Moscoso del Prado, J.
Integrating Reinforcement Learning and PK-PD modelling to enable precision dosing: a multi-objective optimization for the treatment of Polycithemia Vera patients with Givinostat
2023-01-01 De Carlo, A.; Tosca, E. M.; Magni, P.
Integration of response, tolerability and dropout in flexible-dose trials: a case study in depression
2011-01-01 Russu, Alberto; Marostica, Eleonora; DE NICOLAO, Giuseppe; A. C., Hooker; Poggesi, Italo; R., Gomeni; S., Zamuner
Landscape on technical and conceptual requirements in Drug/Disease Modelling & Simulation
2012-01-01 G., Vlasakakis; E., Comets; A., Drescher; I., Gueorguieva; Magni, Paolo; Terranova, Nadia; O., Della Pasqua; E. C., de Lange; C., Kloft
Mathematical models of tumor growth inhibition in xenograft mice after administration of anticancer agents given in combination
2013-01-01 Terranova, Nadia; Germani, MASSIMILIANO ENRICO; DEL BENE, Francesca; Magni, Paolo
Mechanistic multi-scale systems pharmacokinetics model applied for the anticancer drug Gemcitabine in pancreatic cancer
2017-01-01 Garcia Cremades, M.; Melillo, Nicola; Magni, Paolo; Troconiz, I. F.
Methods and tools for multiscale modelling in Systems Pharmacology: a review
2016-01-01 Borella, Elisa; Carrara, Letizia; Lavezzi, SILVIA MARIA; Massaiu, Ilaria; Sauta, Elisabetta; Tosca, ELENA MARIA; Vitali, Francesca; Zucca, Susanna; Pasotti, Lorenzo; DE NICOLAO, Giuseppe; Magni, Paolo
Model Description Language (MDL) - a standard for model communication and interoperability
2016-01-01 Smith, Mk; Moodie, S; Bizzotto, R; Blaudez, E; Borella, Elisa; Carrara, Letizia; Chan, P; Chenel, M; Comets, E; Gieschke, R; Harling, K; Harnisch, L; Hartung, N; Hooker, A; Karlsson, Mo; Kaye, R; Kloft, C; Kokash, N; Lavielle, M; Magni, Paolo; Mari, A; Mentre, F; Muselle, C; Nordgren, R; Nyberg, H; Parra Guillen, Zp; Pasotti, Lorenzo; Rode Kristensen, N; Smith, G; Swat, Mj; Terranova, Nadia; Yvon, F; Holford, NICHOLAS HUGH GEORGE
Model-based analysis of patient-derived organoids for evaluating anticancer drugs
2023-01-01 Ronchi, D.; Tosca, E. M.; De Siervi, S.; Turato, C.; Lolicato, M. G.; Magni, P.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Evaluating the inclusion of the particle size distribution in the lung dissolution model of a WB-PBPK model to describe the pharmacokinetics of inhaled polydisperse drugs | 1-gen-2018 | Grandoni, S.; Cesari, N.; Brogin, G.; Puccini, P.; Magni, P. | |
Evaluating the Influence of Different Sources of Variability in the PK/PD Tumor Growth Inhibition (TGI) Model | 1-gen-2008 | F., Del Bene; M., Germani; F., Fiorentini; DE NICOLAO, Giuseppe; Magni, Paolo; M., Rocchetti | |
Evaluation of a minimal WB-PBPK platform supporting different routes of administration | 1-gen-2017 | Grandoni, Silvia; Bigoni, Giulia; Cesari, N.; Puccini, P.; Brogin, G.; Magni, Paolo | |
Evaluation of a PK/PD DEB-based model for tumor-in-host growth kinetics under anticancer treatment | 1-gen-2016 | Tosca, ELENA MARIA; Borella, Elisa; Terranova, Nadia; Rocchetti, M.; Magni, Paolo | |
Evaluation of software tools for Bayesian estimation on population models with count and continuous data | 1-gen-2015 | Borella, Elisa; Carrara, Letizia; Lavezzi, SILVIA MARIA; Mezzalana, Enrica; Pasotti, Lorenzo; DE NICOLAO, Giuseppe; Magni, Paolo | |
Evaluation of software tools for Bayesian estimation on population models:an update based on current software versions | 1-gen-2018 | Bartolucci, R.; Lavezzi, S. M.; Tosca, E. M.; Melillo, N.; Grandoni, S.; Borella, E.; Pasotti, L.; De Nicolao, G.; Magni, P. | |
Execution of complex Bayesian workflows with the DDMoRe Interoperability Framework: a case study in the diabetes area | 1-gen-2017 | Larizza, Cristiana; Borella, Elisa; Pasotti, Lorenzo; Tartaglione, Palma; Smith, M.; Moodie, S.; Magni, Paolo | |
Facing the limits of the genetic algorithms for covariate selection | 1-gen-2022 | Ronchi, D.; Tosca, E. M.; Ravasi, I.; Bartolucci, R.; Magni, P. | |
First-order longitudinal population model of FEV1 data: single-trial modeling and meta-analysis | 1-gen-2013 | Marostica, Eleonora; S., Yang; Russu, Alberto; DE NICOLAO, Giuseppe; S., Zamuner; M., Beerahee | |
Global sensitivity analysis of a physiologically based pulmonary absorption model | 1-gen-2019 | Melillo, N.; Grandoni, S.; Cesari, N.; Brogin, G.; Puccini, P.; Magni, P. | |
Impact of sampling procedure on individual pharmacokinetic parameter estimation methods | 1-gen-2024 | Cuquerella-Gilabert, M.; Sanchez Herrero, S.; Merino Sanjuan, M.; Tosca, E. M.; Mangas Sanjuan, V.; Magni, P. | |
In vitro-in vivo correlation (IVIVC) population modeling for the in silico bioequivalence of a long-acting release formulation of Progesterone | 1-gen-2018 | Tosca, E. M.; De Nicolao, G.; Rochetti, M.; Magni, P.; Perez, E.; Nieto, C.; Bettica, P.; Moscoso del Prado, J. | |
Integrating Reinforcement Learning and PK-PD modelling to enable precision dosing: a multi-objective optimization for the treatment of Polycithemia Vera patients with Givinostat | 1-gen-2023 | De Carlo, A.; Tosca, E. M.; Magni, P. | |
Integration of response, tolerability and dropout in flexible-dose trials: a case study in depression | 1-gen-2011 | Russu, Alberto; Marostica, Eleonora; DE NICOLAO, Giuseppe; A. C., Hooker; Poggesi, Italo; R., Gomeni; S., Zamuner | |
Landscape on technical and conceptual requirements in Drug/Disease Modelling & Simulation | 1-gen-2012 | G., Vlasakakis; E., Comets; A., Drescher; I., Gueorguieva; Magni, Paolo; Terranova, Nadia; O., Della Pasqua; E. C., de Lange; C., Kloft | |
Mathematical models of tumor growth inhibition in xenograft mice after administration of anticancer agents given in combination | 1-gen-2013 | Terranova, Nadia; Germani, MASSIMILIANO ENRICO; DEL BENE, Francesca; Magni, Paolo | |
Mechanistic multi-scale systems pharmacokinetics model applied for the anticancer drug Gemcitabine in pancreatic cancer | 1-gen-2017 | Garcia Cremades, M.; Melillo, Nicola; Magni, Paolo; Troconiz, I. F. | |
Methods and tools for multiscale modelling in Systems Pharmacology: a review | 1-gen-2016 | Borella, Elisa; Carrara, Letizia; Lavezzi, SILVIA MARIA; Massaiu, Ilaria; Sauta, Elisabetta; Tosca, ELENA MARIA; Vitali, Francesca; Zucca, Susanna; Pasotti, Lorenzo; DE NICOLAO, Giuseppe; Magni, Paolo | |
Model Description Language (MDL) - a standard for model communication and interoperability | 1-gen-2016 | Smith, Mk; Moodie, S; Bizzotto, R; Blaudez, E; Borella, Elisa; Carrara, Letizia; Chan, P; Chenel, M; Comets, E; Gieschke, R; Harling, K; Harnisch, L; Hartung, N; Hooker, A; Karlsson, Mo; Kaye, R; Kloft, C; Kokash, N; Lavielle, M; Magni, Paolo; Mari, A; Mentre, F; Muselle, C; Nordgren, R; Nyberg, H; Parra Guillen, Zp; Pasotti, Lorenzo; Rode Kristensen, N; Smith, G; Swat, Mj; Terranova, Nadia; Yvon, F; Holford, NICHOLAS HUGH GEORGE | |
Model-based analysis of patient-derived organoids for evaluating anticancer drugs | 1-gen-2023 | Ronchi, D.; Tosca, E. M.; De Siervi, S.; Turato, C.; Lolicato, M. G.; Magni, P. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile